91 related articles for article (PubMed ID: 24851608)
1. Association study of cytochrome P450 1A1*2A polymorphism with prostate cancer risk and aggressiveness in Croatians.
Mandić S; Horvat V; Marczi S; Lukić I; Galić J
Coll Antropol; 2014 Mar; 38(1):141-6. PubMed ID: 24851608
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of CYP1A1 polymorphism with prostate cancer susceptibility of Tunisian men.
Souiden Y; Mahdouani M; Chaieb K; Bakhrouf A; Mahdouani K
Genet Test Mol Biomarkers; 2012 Jul; 16(7):661-6. PubMed ID: 22304463
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population.
Aktas D; Hascicek M; Sozen S; Ozen H; Tuncbilek E
Cancer Genet Cytogenet; 2004 Oct; 154(1):81-5. PubMed ID: 15381379
[TBL] [Abstract][Full Text] [Related]
5. Association of IL-1β and IL-10 Polymorphisms with Prostate Cancer Risk and Grade of Disease in Eastern Croatian Population.
Horvat V; Mandić S; Marczi S; Mrčela M; Galić J
Coll Antropol; 2015 Jun; 39(2):393-400. PubMed ID: 26753456
[TBL] [Abstract][Full Text] [Related]
6. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor GGC polymorphism and testosterone levels associated with high risk of prostate cancer and benign prostatic hyperplasia.
Biolchi V; Silva Neto B; Pianta DB; Koff WJ; Berger M; Brum IS
Mol Biol Rep; 2013 Mar; 40(3):2749-56. PubMed ID: 23184046
[TBL] [Abstract][Full Text] [Related]
9. Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.
Samzadeh M; Hasanzad M; Jamaldini SH; Haghdoost AA; Afshari M; Ziaee SA
Urol J; 2012; 9(4):691-9. PubMed ID: 23235975
[TBL] [Abstract][Full Text] [Related]
10. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
[TBL] [Abstract][Full Text] [Related]
11. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer.
Aydin M; Bozkurt A; Cikman A; Gulhan B; Karabakan M; Gokce A; Alper M; Kara M
Int Braz J Urol; 2017; 43(1):36-46. PubMed ID: 28124524
[TBL] [Abstract][Full Text] [Related]
12. Association of caspases with an increased prostate cancer risk in north Indian population.
Mittal RD; Mittal T; Singh AK; Mandal RK
DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
[TBL] [Abstract][Full Text] [Related]
13. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
[TBL] [Abstract][Full Text] [Related]
14. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
15. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
16. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
[TBL] [Abstract][Full Text] [Related]
17. CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer.
Kumar V; Yadav CS; Singh S; Goel S; Ahmed RS; Gupta S; Grover RK; Banerjee BD
Chemosphere; 2010 Sep; 81(4):464-8. PubMed ID: 20817259
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 polymorphism and prostate cancer risk in population of Eastern Croatia.
Mandić S; Sudarević B; Marczi S; Horvat V; Cosić I; Mihaljević S; Milicević N; Simunović D; Galić J
Coll Antropol; 2013 Sep; 37(3):907-11. PubMed ID: 24308236
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
Avgeris M; Stravodimos K; Scorilas A
Prostate; 2011 Dec; 71(16):1780-9. PubMed ID: 21520157
[TBL] [Abstract][Full Text] [Related]
20. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
Safarinejad MR; Shafiei N; Safarinejad S
Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
